Single-cell transcriptomic analysis reveals intra-tumoral heter-ogeneity and immunotherapy strategies in high-grade serous ovarian cancer

Documenti analoghi

• B cells critical for outcome in high grade serous ovarian carcinoma
  di: Annegé Vledder, et al.
  Pubblicazione: (2024)
• Revisiting intraperitoneal chemotherapy for advanced high‐grade serous ovarian cancer
  di: Joshua S Cheruvathur, et al.
  Pubblicazione: (2025)
• Establishment of a humanized patient‐derived xenograft mouse model of high‐grade serous ovarian cancer for preclinical evaluation of combination immunotherapy
  di: Luka Tandaric, et al.
  Pubblicazione: (2026)
• Plasma membrane SK2 channel activity regulates migration and chemosensitivity of high‐grade serous ovarian cancer cells
  di: Olivier Romito, et al.
  Pubblicazione: (2024)
• Identification of potential cell surface targets in patient‐derived cultures toward photoimmunotherapy of high‐grade serous ovarian cancer
  di: Sudip Timilsina, et al.
  Pubblicazione: (2025)